Woman in Lab pointing at Diagnostic Screen

Bioanalysis Division

MTBI2’s Bioanalysis Division is a collaborative platform that supports high-dimensional multiplex protein and RNA analysis within traumatic brain injury (TBI) studies. Its expertly skilled scientific team, advanced technologies, and data comprehension support yields powerful insights to the pathophysiology and brain function after TBIs.

Our Bioanalysis Division provides unique technological resources that are often unavailable to individual laboratories due to costs, complexity, novelty, and specialized expertise. Its technological support includes, but is not limited to, ultra-sensitive neurological and neuroinflammation biomarker studies, proteomics, transcriptomics, and novel technology development.
The Bioanalysis Division’s current technological platforms include:

  • Microbead based ultra-sensitive biomarker analysis _ SIMOA HD-X Analyzer
  • Planar biomarker analysis _ Meso Scale Discovery and SP-X
  • Proteomics
  • Transcriptomics - nCounter Pro
  • Nanoparticle Tracking Analysis and colocalization _ ZetaView Quatt

MTBI2’s Bioanalysis Division can also assist collaborators with study design and data generation via pathophysiological interpretation with our Informatics Division. The Bioanalysis Division is particularly interested in collaborating with researchers working on clinical studies or developing technology that will benefit the broader TBI research community. 

Interested in working with us? Contact MTBI2-bioanalysis@usuhs.edu to learn more about its capabilities.